SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-024166
Filing Date
2020-05-11
Accepted
2020-05-11 16:05:36
Documents
15
Period of Report
2020-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - Q1'20 EARNINGS PRESS RELEASE tlry-8k_20200511.htm   iXBRL 8-K 40083
2 EX-99 tlry-ex99_6.htm EX-99 577779
3 GRAPHIC g132avooqroj000002.jpg GRAPHIC 7838
4 GRAPHIC g132avooqroj000001.jpg GRAPHIC 14787
  Complete submission text file 0001564590-20-024166.txt   806977

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tlry-20200511.xsd EX-101.SCH 5768
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20200511_lab.xml EX-101.LAB 19435
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20200511_pre.xml EX-101.PRE 11611
16 EXTRACTED XBRL INSTANCE DOCUMENT tlry-8k_20200511_htm.xml XML 3534
Mailing Address 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2
Business Address 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2 2064329325
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 20864743
SIC: 2833 Medicinal Chemicals & Botanical Products